Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip

Journey Medical Corporation (NASDAQ: DERM) Listen to this Section


$4.46
-0.1000 ( -2.19% ) 59.8K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open


$4.46

Previous close


$4.56

Volume


59.8K

Market cap


$91.82M

Day range


$4.39 - $4.96

52 week range


$1.78 - $8.11

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 25, 2024
4 Insider transactions 1 Mar 25, 2024
4 Insider transactions 1 Mar 25, 2024
8-k 8K-related 15 Mar 21, 2024
4 Insider transactions 1 Feb 23, 2024
8-k 8K-related 14 Jan 02, 2024
4 Insider transactions 1 Dec 08, 2023
8-k 8K-related 12 Dec 08, 2023
4 Insider transactions 1 Nov 29, 2023
10-q Quarterly Reports 90 Nov 13, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.